- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Biopharma Sustainability Roundtable Releases Biopharma Investor ESG Communications Guidance Update
The Biopharma Sustainability Roundtable (BSRT) has released the Biopharma Investor ESG Communications Guidance 4.0, a resource for strategic thinking and planning of biopharma-investor ESG communications. The outcome of an ongoing dialog facilitated by the BSRT, the guidance reflects a biopharma-investor consensus on the sector’s priority ESG topics and offers recommendations on what and resources for how biopharma companies can most effectively communicate with investors about ESG strategy, governance, risks, opportunities, and performance. The Guidance 4.0 has been validated and improved through use-case experience by both biopharma and investors, and additional input from key stakeholders.
Read more about the guidance update here.
Fierce Females in the Life Science Space
March 29th 2024In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.
